Stock and Flow of Peritoneal Dialysis Patients Australia

Slides:



Advertisements
Similar presentations
ANZDATA Registry Annual Report 2013 STOCK AND FLOW CHAPTER 1.
Advertisements

World population: 6.7 billion Global Prevalence Patients per million population (p.m.p.) Global View of ESRD Patients World population 1.2% ESRD~ 7% Haemodialysis7-8%
End Stage Kidney Disease Treatment Modalities Australia New Zealand Dec 2012 Prepared by Debbie Fortnum Kidney Health Australia Data courtesy of ANZDATA.
HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients Australia Patients new.
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate
Kevan Polkinghorne Aarti Gulyani Stephen McDonald Kylie Hurst CHAPTER 5 HAEMODIALYSIS (including home haemodialysis) 2012 Annual Report—35th Edition ANZDATA.
© ANZDATA Registry PEADIATRIC CHAPTER CHAPTER 11.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11.
CHAPTER 2 DIALYSIS IN MALAYSIA Goh Bak Leong Lim Yam Ngo Ong Loke Meng Ghazali Ahmad Lee Day Guat Source: 21 st MDTR Report 2013, NRR.
ANZDATA Registry Overview Dr Graeme Russ Darwin September 2001 September 2001.
CHAPTER 1: ALL RENAL REPLACEMENT THERAPY IN MALAYSIA Lim Yam Ngo Ong Loke Meng Goh Bak Leong Lee Day Guat Source: 20 th MDTR Report 2012, NRR.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
© ANZDATA Registry Method and Location of Dialysis (31%) 634 (12%) 1396 (26%) 1523 (28%) Number of Patients Australia 30-Sep-98 METHA.BRIS98.
Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 3: Clinical Indicators and Preventive Care.
© ANZDATA Registry Prevalence and Incidence End Stage Renal Failure - Australia ( ) Per Million Functioning Transplant (259) New Pts (82) Deaths.
UK Renal Registry 16th Annual Report Figure Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
STOCK AND FLOW CHAPTER 1. © ANZDATA Registry Figure 1.1 Prevalent Patients (Number Per Million Population at 31st December)
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 1 STOCK AND FLOW 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
© ANZDATA Registry Stock and Flow of CAPD Patients Australia Number of Patients 1504 Patients * (Data to 30 Sept) Extrapolated.
Chapter 1 ALL RENAL REPLACEMENT THERAPY IN MALAYSIA
UK Renal Registry 10th Annual Report 2007 Fig 9.1 Annual change in percentage of dialysis patients with serum phosphate < 1.8mmol/L and ≥1.1 -≤1.8mmol/L.
END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.
Figure 3.1 ESRD clinical indicators, CROWNWeb data, December 2015
Routine Monitoring of Sodium and Phosphorus Removal in Peritoneal Dialysis (PD) Patients Treated with Continuous Ambulatory PD (CAPD), Automated PD (APD)
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
UK Renal Registry 18th Annual Report
First-year death rates by modality figure 8
Prevalence (pmp) of Renal Replacement Therapy
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
Fig 7.1 Median URR achieved in each renal unit
December 31st point prevalent counts by modality figure 3.1
Chapter 2: Clinical Indicators and Preventive Care
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani
2013 Annual Report - 36th Edition
CHAPTER 5 Paediatric Renal Replacement Therapy
CHAPTER 7 Nutritional Status on Dialysis
Iron status and iron supplementation in peritoneal dialysis patients
Volume 2: End-Stage Renal Disease
METHOD AND LOCATION OF DIALYSIS CHAPTER 4.
Volume 64, Pages S3-S12 (December 2003)
CHAPTER 1 All Renal Replacement Therapy In Malaysia
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
Erratum Regarding “Phosphate Removal With Several Thrice-Weekly Dialysis Methods in Overweight Hemodialysis Patients” [Am J Kidney Dis 2009; 54: ] 
Cause Specific Death Rates for All Dialysis Patients
UK Renal Registry 16th Annual Report
2013 Annual Report - 36th Edition
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
UK Renal Registry 14th Annual Report
American Journal of Kidney Diseases
Mary B. Leonard, Lynn A. Donaldson, Martin Ho, Denis F. Geary 
Dialysis outcomes in Australia & New Zealand
ANZDATA Peritoneal Dialysis Report
Stock and Flow of Haemodialysis Patients Australia
Prevalent Dialysis and Transplants Australia (at 31st December) Number of Patients
Demographic Characteristics of Cohort
Stock and Flow of Peritoneal Dialysis Patients Australia
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Haemodialysis Patients Australia
Australia and New Zealand
Australia and New Zealand
Presentation transcript:

Stock and Flow of Peritoneal Dialysis Patients Australia 2004 - 2008 Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 2205 Patients 2004 2005 2006 2007 2008

Stock and Flow of Peritoneal Dialysis Patients New Zealand 2004 - 2008 Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 762 Patients 2004 2005 2006 2007 2008

Age of New PD Patients 2008 Australia No. Pats. 15 32 49 101 172 204 219 161 12

Age of Dialysing PD Patients 31-Dec-2008 Australia No. Pats. 29 47 81 184 367 491 544 415 47

PD Patients (%) of all Prevalent Dialysis Australia 31-Dec-2008

Number (Per Million) Prevalent PD Patients Australia 2004 - 2008 % Diab 26% 28% 29% 29% 29%

Number of Prevalent APD/CAPD Patients Australia 2004 - 2008 % APD 43% 44% 48% 54% 57%

PD Patients (%) of all Prevalent Dialysis New Zealand 31-Dec-2008

Number (Per Million) Prevalent PD Patients New Zealand 2004 - 2008 % Diab 38% 40% 38% 39% 38%

Number of Prevalent APD/CAPD Patients New Zealand 2004 - 2008 % APD 24% 26% 29% 33% 38%

Age of New PD Patients 2008 New Zealand No. Pats. 10 13 11 21 55 76 69 17 0

Age of Dialysing PD Patients New Zealand 31-Dec-2008 No. Pats. 13 29 30 62 143 206 186 80 13

Haemoglobin – Peritoneal Dialysis December 2006 - 2008 Hb (g/L) Australia New Zealand

Haemoglobin - Peritoneal Dialysis By Coronary Artery Disease Status Australia - December 2006 - 2008 Hb (g/L) No CAD CAD

Haemoglobin - Peritoneal Dialysis By Coronary Artery Disease Status New Zealand - December 2006 - 2008 Hb (g/L) No CAD CAD

Ferritin – Peritoneal Dialysis December 2006 - 2008 mcg/L Australia New Zealand

Transferrin Saturation – Peritoneal Dialysis December 2006 - 2008 T/Sat (%) Australia New Zealand

Serum Calcium – Peritoneal Dialysis December 2006 - 2008 Calcium (mmol/L) Australia New Zealand

Serum Phosphate – Peritoneal Dialysis December 2006 - 2008 Phosphate (mmol/L) Australia New Zealand

Calcium Phosphate Product – Peritoneal Dialysis December 2006 - 2008 Ca X P (mmol2/L2) Australia New Zealand

Prevalent Patients – December 2008 Icodextrin Usage by Modality Australia New Zealand

v Prevalent Patients – December 2008 Icodextrin Usage by State and New Zealand CAPD APD

Prevalent Patients – December 2008 Low GDP – Lactate Usage by Modality Australia New Zealand

Prevalent Patients – December 2008 Low GDP – Bicarb Usage by Modality Australia New Zealand

Number of Episodes per Patient Year and Patients Months per Episode 2003/4 - 2008

Number of PD Episodes per Person Australia 2003 - 2008

Percentage of Peritonitis Episodes

Peritonitis in Australia Episodes during 2008

Initial Antibiotic Regimen

Vancomycin/Gentamicin by Regimen

Proportion of Episodes Resulting in Permanent Haemodialysis Transfer

Peritonitis Rates by Treating Unit All Episodes 2003 -2008 Australia only

Peritonitis Rates by Treating Unit 2008 Only Australia only

Rates of Peritonitis by State 2003 - 2008